Cyclacel Pharmaceuticals to Release First Quarter 2023 Financial Results
Provided By Globe NewsWire
Last update: May 4, 2023
BERKELEY HEIGHTS, N.J., May 04, 2023 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce first quarter 2023 financial results on Thursday, May 11, 2023. The Company will host a conference call and live webcast at 4:30 p.m. Eastern Daylight Time on the same day.
Conference call information:
US/Canada call: (800) 274-8461 / international call: (203) 518-9783
US/Canada archive: (800) 839-6975 / international archive: (402) 220-6061
Code for live and archived conference call is CYCCQ123. Webcast link
For the live and archived webcast, please visit the Corporate Presentations page on the Cyclacel website at www.cyclacel.com. The webcast will be archived for 90 days and the audio replay for 7 days.
About Cyclacel Pharmaceuticals, Inc.
Cyclacel is a clinical-stage, biopharmaceutical company developing innovative cancer medicines based on cell cycle, transcriptional regulation and mitosis biology. The transcriptional regulation program is evaluating fadraciclib, a CDK2/9 inhibitor, and the anti-mitotic program plogosertib, a PLK1 inhibitor, in patients with both solid tumors and hematological malignancies. Cyclacel’s strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates addressing oncology and hematology indications. For additional information, please visit www.cyclacel.com.
Contacts
| Company: | Paul McBarron, (908) 517-7330, pmcbarron@cyclacel.com |
| Investor Relations: | Grace Kim, IR@cyclacel.com |
© Copyright 2023 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The Cyclacel logo and Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc.
NASDAQ:CYCC (5/12/2025, 3:56:24 PM)
3.54
+3.29 (+1316%)
CYCLACEL PHARMACEUTICALS - CYCC 6 PERP
NASDAQ:CYCCP (5/8/2025, 8:00:01 PM)
4.05
+0.31 (+8.29%)
Find more stocks in the Stock Screener
CYCC Latest News and Analysis
7 days ago - ChartmillMonday's session: top gainers and losersHere are the top movers in Monday's session, showcasing the stocks with significant price changes.
12 days ago - ChartmillUnusual volume stocks are being observed in Wednesday's session.In today's session, there are stocks attracting attention with their unusual volume. Let's take a closer look.
12 days ago - ChartmillThese stocks that are showing activity before the opening bell on Wednesday.Before the US market kicks off on Wednesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.
13 days ago - ChartmillGet insights into the top gainers and losers of Tuesday's after-hours session.As the regular session of the US market concludes on Tuesday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses.
13 days ago - ChartmillIn today's session, these stocks are experiencing unusual volume.Let's have a look at the stocks with an unusual volume in today's session.
13 days ago - ChartmillThese stocks are gapping in today's sessionLet's have a look at the gap up and gap down stocks in today's session.
13 days ago - ChartmillTop movers in Tuesday's pre-market sessionWondering what's happening in Tuesday's pre-market session? Find an overview in this article.
14 days ago - ChartmillCurious about the stocks that are showing activity after the closing bell on Monday?Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.
